Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_assertion type Assertion NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_head.
- NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_assertion description "[A proportion of Alzheimer's disease (AD) patients treated for several months with cholinesterase (ChE) inhibitors have shown some favorable response on cognition, but the characteristics of the responders are still unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_provenance.
- NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_assertion evidence source_evidence_literature NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_provenance.
- NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_assertion SIO_000772 11125238 NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_provenance.
- NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_assertion wasDerivedFrom befree-2016 NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_provenance.
- NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_assertion wasGeneratedBy ECO_0000203 NP303623.RAlCYHktKxsL2b8qTq4_dWLwLq7VcDRIRc55Ru_5agv7U130_provenance.